Home/Filings/4/0001415889-23-008701
4//SEC Filing

Jensen Claus Torp 4

Accession 0001415889-23-008701

CIK 0001477449other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:06 PM ET

Size

11.3 KB

Accession

0001415889-23-008701

Insider Transaction Report

Form 4
Period: 2023-05-22
Jensen Claus Torp
Chief Innovation Officer
Transactions
  • Award

    Performance Stock Units

    2023-05-22+9,1919,191 total
    Common Stock (9,191 underlying)
  • Sale

    Common Stock

    2023-05-23$24.44/sh2,888$70,58019,843 total
  • Exercise/Conversion

    Performance Stock Units

    2023-05-229,1910 total
    Common Stock (9,191 underlying)
  • Exercise/Conversion

    Common Stock

    2023-05-22+9,19122,731 total
Footnotes (6)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit awards.
  • [F3]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F4]Performance award amount determined based on the achievement of certain research and development targets over a two-year performance period.
  • [F5]The performance stock units vested on May 22, 2023.
  • [F6]On May 22, 2023, the reporting person earned 9,191 performance stock units, vesting on May 22, 2023.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001857993

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:06 PM ET
Size
11.3 KB